Literature DB >> 10792293

Proliferative involvement of ENX-1, a putative human polycomb group gene, in haematopoietic cells.

T Fukuyama1, T Otsuka, H Shigematsu, N Uchida, F Arima, Y Ohno, H Iwasaki, T Fukuda, Y Niho.   

Abstract

Homeobox genes have important roles in haematopoiesis and are regulated in an activated state by the trithorax group (trxG) of genes. In a repressed state, they are regulated by the Polycomb group (PcG) of genes. ENX-1, a putative human PcG gene product, interacts with the proto-oncogene product Vav. We report an investigation of the role of ENX-1 in human haematopoiesis. CD34+ cells mobilized to peripheral blood strongly expressed ENX-1. When stimulated to proliferate, both T and B lymphocytes rapidly up-regulated ENX-1. ENX-1 was expressed in all cell lines of the various lineages examined. When HL-60 cells were differentiated to mature granulocytes with all-trans retinoic acid, ENX-1 was down-regulated. Moreover, ENX-1 antisense oligodeoxynucleotide suppressed DNA synthesis in HL-60 cells. Our data indicate that ENX-1 is involved in the proliferation of both normal and malignant haematopoietic cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10792293     DOI: 10.1046/j.1365-2141.2000.01914.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  10 in total

Review 1.  The Polycomb group protein Enhancer of Zeste 2: its links to DNA repair and breast cancer.

Authors:  Michael Zeidler; Celina G Kleer
Journal:  J Mol Histol       Date:  2006-07-20       Impact factor: 2.611

2.  Epigenetic dysregulation in cancer.

Authors:  Andrew G Muntean; Jay L Hess
Journal:  Am J Pathol       Date:  2009-08-28       Impact factor: 4.307

3.  The Polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion.

Authors:  Leonie M Kamminga; Leonid V Bystrykh; Aletta de Boer; Sita Houwer; José Douma; Ellen Weersing; Bert Dontje; Gerald de Haan
Journal:  Blood       Date:  2005-11-17       Impact factor: 22.113

Review 4.  Connections between epigenetic gene silencing and human disease.

Authors:  Timothy J Moss; Lori L Wallrath
Journal:  Mutat Res       Date:  2007-01-21       Impact factor: 2.433

5.  Expression and clinicopathological significance of Mel-18 and Bmi-1 mRNA in gastric carcinoma.

Authors:  You-Wei Lu; Jin Li; Wei-Jian Guo
Journal:  J Exp Clin Cancer Res       Date:  2010-11-08

6.  EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer.

Authors:  Adrian P Bracken; Diego Pasini; Maria Capra; Elena Prosperini; Elena Colli; Kristian Helin
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

Review 7.  Targeting EZH2 for cancer therapy: progress and perspective.

Authors:  Chi Han Li; Yangchao Chen
Journal:  Curr Protein Pept Sci       Date:  2015       Impact factor: 3.272

8.  Blocking EZH2 methylation transferase activity by GSK126 decreases stem cell-like myeloma cells.

Authors:  Delong Zeng; Maoxing Liu; Jingxuan Pan
Journal:  Oncotarget       Date:  2017-01-10

9.  Ezh2 promotes clock function and hematopoiesis independent of histone methyltransferase activity in zebrafish.

Authors:  Yingbin Zhong; Qiang Ye; Chengyan Chen; Mingyong Wang; Han Wang
Journal:  Nucleic Acids Res       Date:  2018-04-20       Impact factor: 16.971

Review 10.  EZH2 in normal hematopoiesis and hematological malignancies.

Authors:  Laurie Herviou; Giacomo Cavalli; Guillaume Cartron; Bernard Klein; Jérôme Moreaux
Journal:  Oncotarget       Date:  2016-01-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.